200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 82186-77-4

82186-77-4

82186-77-4 | (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol

CAS No: 82186-77-4 Catalog No: AG0036KV MDL No:MFCD05662268

Product Description

Catalog Number:
AG0036KV
Chemical Name:
(9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol
CAS Number:
82186-77-4
Molecular Formula:
C30H32Cl3NO
Molecular Weight:
528.9402
MDL Number:
MFCD05662268
IUPAC Name:
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
InChI:
InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-
InChI Key:
DYLGFOYVTXJFJP-MYYYXRDXSA-N
SMILES:
CCCCN(CC(c1cc(Cl)cc2c1c1ccc(cc1/C/2=C/c1ccc(cc1)Cl)Cl)O)CCCC
EC Number:
617-303-4

Properties

Complexity:
671  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
527.155g/mol
Formal Charge:
0
Heavy Atom Count:
35  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
528.942g/mol
Monoisotopic Mass:
527.155g/mol
Rotatable Bond Count:
10  
Topological Polar Surface Area:
23.5A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
8.7  

Literature

Title Journal
Breakdown of phosphatidylserine asymmetry following treatment of erythrocytes with lumefantrine. Toxins 20140201
In vitro and in vivo combination of cepharanthine with anti-malarial drugs. Malaria journal 20140101
Ex vivo responses of Plasmodium falciparum clinical isolates to conventional and new antimalarial drugs in Niger. Antimicrobial agents and chemotherapy 20130701
Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs. Journal of medicinal chemistry 20130328
A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Malaria journal 20130101
Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine. The Journal of antimicrobial chemotherapy 20121001
Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication? Parasitology research 20120801
Increased urinary frequency: an unusual presentation of Plasmodium falciparum malaria. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20120701
Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. Colloids and surfaces. B, Biointerfaces 20120615
Gender differences in pharmacokinetics of lumefantrine and its metabolite desbutyl-lumefantrine in rats. Biopharmaceutics & drug disposition 20120501
Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine. The American journal of tropical medicine and hygiene 20120301
Successful oral therapy for severe falciparum malaria: the World Health Organization criteria revisited. The American journal of tropical medicine and hygiene 20120301
Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation. Bioanalysis 20120101
Falciparum--the masquerader. JPMA. The Journal of the Pakistan Medical Association 20120101
Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure. PloS one 20120101
The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum. Malaria journal 20120101
In vitro sensitivity of Plasmodium falciparum from China-Myanmar border area to major ACT drugs and polymorphisms in potential target genes. PloS one 20120101
Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy. The American journal of tropical medicine and hygiene 20111201
In vitro activity of antiretroviral drugs against Plasmodium falciparum. Antimicrobial agents and chemotherapy 20111101
Pharmacokinetics of antimalarials in pregnancy: a systematic review. Clinical pharmacokinetics 20111101
Plasmodium species co-infection as a cause of treatment failure. Travel medicine and infectious disease 20111101
The pharmacogenetics of antimalaria artemisinin combination therapy. Expert opinion on drug metabolism & toxicology 20111001
Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States. The American journal of tropical medicine and hygiene 20111001
Synthesis of novel 6-phenyl-2,4-disubstituted pyrimidine-5-carbonitriles as potential antimicrobial agents. European journal of medicinal chemistry 20110901
Severe Plasmodium knowlesi malaria in a tertiary care hospital, Sabah, Malaysia. Emerging infectious diseases 20110701
Plasmodium knowlesi reinfection in human. Emerging infectious diseases 20110701
In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs. Antimicrobial agents and chemotherapy 20110501
Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum. PLoS genetics 20110401
Plasmodium berghei K173: selection of resistance to naphthoquine in a mouse model. Experimental parasitology 20110201
Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: application for a pharmacokinetic study. Journal of pharmaceutical and biomedical analysis 20110105
Measurement of lumefantrine and its metabolite in plasma by high performance liquid chromatography with ultraviolet detection. Journal of pharmaceutical and biomedical analysis 20110105
Automated erythrocytapheresis for severe falciparum malaria. Internal medicine journal 20110101
Stability-indicating HPLC-DAD/UV-ESI/MS impurity profiling of the anti-malarial drug lumefantrine. Malaria journal 20110101
Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance. PloS one 20110101
Comparative study of the efficacy and tolerability of dihydroartemisinin-piperaquine-trimethoprim versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal. Malaria journal 20110101
Intravenous pharmacokinetics, oral bioavailability, dose proportionality and in situ permeability of anti-malarial lumefantrine in rats. Malaria journal 20110101
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Malaria journal 20110101
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Journal of tropical pediatrics 20101201
Artemisinin-based combination therapies and their introduction in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20101201
Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. The American journal of tropical medicine and hygiene 20101105
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria. The American journal of tropical medicine and hygiene 20101005
Pharmacodynamic interaction between lumefantrine and desbutyl-benflumetol in Plasmodium falciparum in vitro. Wiener klinische Wochenschrift 20101001
Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial. The Journal of infectious diseases 20100815
Dihydroartemisinin-piperaquine versus artemether-lumefantrine, in the treatment of uncomplicated Plasmodium falciparum malaria in central Sudan. Annals of tropical medicine and parasitology 20100601
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Antimicrobial agents and chemotherapy 20100501
Pyronaridine-artesunate for uncomplicated falciparum malaria. Lancet (London, England) 20100424
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Lancet (London, England) 20100424
The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Tropical medicine & international health : TM & IH 20100401
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrobial agents and chemotherapy 20100301
A semi-automated method for counting fluorescent malaria oocysts increases the throughput of transmission blocking studies. Malaria journal 20100101
Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. PloS one 20100101
Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091015
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers. Journal of acquired immune deficiency syndromes (1999) 20090801
Artemisinin-based combination therapy for treating uncomplicated malaria. The Cochrane database of systematic reviews 20090708
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model. Experimental parasitology 20090701
Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. The Journal of infectious diseases 20090701
Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. British journal of haematology 20090601
First artemisinin-based antimalarial combination approved for U.S. market. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malaria. The American journal of tropical medicine and hygiene 20090501
Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415
A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma. Bioanalysis 20090401
Antimalarial therapies in children from Papua New Guinea. The New England journal of medicine 20090319
Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria? The American journal of tropical medicine and hygiene 20090101
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PloS one 20090101
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PloS one 20090101
Cardiac complication after experimental human malaria infection: a case report. Malaria journal 20090101
A field-adapted sampling and HPLC quantification method for lumefantrine and its desbutyl metabolite in whole blood spotted on filter paper. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20081215
A trial of combination antimalarial therapies in children from Papua New Guinea. The New England journal of medicine 20081211
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. PLoS medicine 20081201
Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection. Journal of pharmaceutical and biomedical analysis 20081104
A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. The American journal of tropical medicine and hygiene 20081101
Comparison of HPLC, UV spectrophotometry and potentiometric titration methods for the determination of lumefantrine in pharmaceutical products. Journal of pharmaceutical and biomedical analysis 20080910
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene 20080901
Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity. Basic & clinical pharmacology & toxicology 20080901
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Tropical medicine & international health : TM & IH 20080501
The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya. Tropical medicine & international health : TM & IH 20080401
[Efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Hainan, China]. Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases 20080227
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malaria journal 20080101
From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Malaria journal 20080101
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malaria journal 20080101
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PloS one 20080101
Activities of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine against sexual-stage parasites in falciparum malaria in children. Chemotherapy 20080101
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PloS one 20080101
Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. Malaria journal 20080101
Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malaria journal 20080101
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. Malaria journal 20080101
Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malaria journal 20080101
Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malaria journal 20080101
Trends in antimalarial prescriptions in Australia 2002 to 2005. Journal of travel medicine 20080101
Malariological baseline survey and in vitro antimalarial drug resistance in Gulu district, Northern Uganda. Wiener klinische Wochenschrift 20080101
Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro. Wiener klinische Wochenschrift 20080101
Community effectiveness of artemisinin-based combination therapy for malaria in rural southwestern Nigeria. International quarterly of community health education 20080101
[Artemether-lumefantrine, treatment of child more than 5 years old uncomplicated malaria in Tsevie's hospital (Togo)]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20071201
Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clinical pharmacology and therapeutics 20071101
Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. Journal of pharmaceutical and biomedical analysis 20071018
[Treatment of falciparum malaria with artemether-lumefantrine according to a 5-day schedule: results of a study in 21 patients and recommendations]. Nederlands tijdschrift voor geneeskunde 20071006
Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. The Korean journal of parasitology 20070601
In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos). The American journal of tropical medicine and hygiene 20070201
How much fat is necessary to optimize lumefantrine oral bioavailability? Tropical medicine & international health : TM & IH 20070201
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Tropical medicine & international health : TM & IH 20070201
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros]. Bulletin de la Societe de pathologie exotique (1990) 20070201
Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert opinion on pharmacotherapy 20070101
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malaria journal 20070101
Synergistic interaction between monodesbutyl-benflumetol and retinol in Plasmodium falciparum. Wiener klinische Wochenschrift 20070101
Specific pharmacokinetic interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum. Wiener klinische Wochenschrift 20070101
In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh. Wiener klinische Wochenschrift 20070101
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malaria journal 20070101
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. European journal of clinical pharmacology 20061201
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Tropical medicine & international health : TM & IH 20061201
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. The Journal of infectious diseases 20061001
A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. The American journal of tropical medicine and hygiene 20061001
Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. The Journal of infectious diseases 20060815
First Brazilian experience with the use of artemether-lumefantrine (Coartem) a fixed-dosed ACT combination. The American journal of tropical medicine and hygiene 20060801
The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya. Tropical medicine & international health : TM & IH 20060801
Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Tropical medicine & international health : TM & IH 20060701
High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. The American journal of tropical medicine and hygiene 20060701
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060601
A case-control auditory evaluation of patients treated with artemether-lumefantrine. The American journal of tropical medicine and hygiene 20060601
Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. The American journal of tropical medicine and hygiene 20060601
Examples of tropical disease control in the humanitarian medical programmes of MSF and Merlin. Transactions of the Royal Society of Tropical Medicine and Hygiene 20060401
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Tropical medicine & international health : TM & IH 20060401
[Malaria: a medical and economic problem]. Presse medicale (Paris, France : 1983) 20060401
Effects of weight, age, and time on artemether-lumefantrine associated ototoxicity and evidence of irreversibility. Travel medicine and infectious disease 20060301
A case-control auditory evaluation of patients treated with artemether-lumefantrine. The American journal of tropical medicine and hygiene 20060201
Successful treatment of Plasmodium falciparum malaria with a six-dose regimen of artemether-lumefantrine versus quinine-doxycycline in the Western Amazon region of Brazil. The American journal of tropical medicine and hygiene 20060101
The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan. Annals of tropical medicine and parasitology 20060101
Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Malaria journal 20060101
Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malaria journal 20060101
From chloroquine to artemisinin-based combination therapy: the Sudanese experience. Malaria journal 20060101
Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. Malaria journal 20060101
Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Malaria journal 20060101
Malaria treatment failures after artemisinin-based therapy in three expatriates: could improved manufacturer information help to decrease the risk of treatment failure? Malaria journal 20060101
Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo. Malaria journal 20060101
The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets. BMC public health 20060101
Artemisinin-based combinations. Current opinion in infectious diseases 20051201
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS medicine 20051101
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051015
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 20051001
Coartem (artemether-lumefantrine) in Africa: the beginning of the end? The Journal of infectious diseases 20051001
High throughput assay for the determination of lumefantrine in plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050805
Safety and efficacy of artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Ethiopia. East African medical journal 20050801
Malaria: uncomplicated, caused by Plasmodium falciparum. Clinical evidence 20050601
Towards a proteomic definition of CoArtem action in Plasmodium falciparum malaria. Proteomics 20050501
Antimalarial drugs: QT prolongation and cardiac arrhythmias. Expert opinion on drug safety 20050501
Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. Journal of pharmaceutical and biomedical analysis 20050429
Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet (London, England) 20050401
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet (London, England) 20050401
In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). The Journal of infectious diseases 20050315
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malaria journal 20050101
Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Tropical medicine & international health : TM & IH 20041101
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. The American journal of tropical medicine and hygiene 20041101
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041015
Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan. Annals of tropical medicine and parasitology 20040901
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Tropical medicine & international health : TM & IH 20040901
Efficacy of artemether-lumefantrine treatment in patients with acute uncomplicated Falciparum malaria in Mayotte, a French collectivity of the Comoros Archipelago. Parasite (Paris, France) 20040901
[Malaria: prophylaxis, treatment, stand-by medication. A single mosquito bite suffices]. MMW Fortschritte der Medizin 20040617
[Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi]. Tropical medicine & international health : TM & IH 20040601
Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert review of anti-infective therapy 20040401
Artemether-lumefantrine for uncomplicated malaria: a systematic review. Tropical medicine & international health : TM & IH 20040201
In vitro sensitivity of Plasmodium falciparum to lumefantrine in north-western Thailand. Wiener klinische Wochenschrift 20040101
Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand. Wiener klinische Wochenschrift 20040101
New antimalarial drugs. Angewandte Chemie (International ed. in English) 20031110
Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. The Southeast Asian journal of tropical medicine and public health 20030901
Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand. The Southeast Asian journal of tropical medicine and public health 20030601
The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria. Fundamental & clinical pharmacology 20030401
Interaction of the antimalarial agents halofantrine and lumefantrine with lipid bilayers. Chemical & pharmaceutical bulletin 20030301
[Three newly registered drugs in the Netherlands for the treatment and chemoprophylaxis of malaria: atovaquone-proguanil, artemether-lumefantrine and artemotil]. Nederlands tijdschrift voor geneeskunde 20030215
Artemether-lumefantrine for treating uncomplicated falciparum malaria. The Cochrane database of systematic reviews 20030101
[Drug resistant tropical malaria in the Republic of Guinea (West Africa)]. Meditsinskaia parazitologiia i parazitarnye bolezni 20030101
Suspected allergy to artemether-lumefantrine treatment of malaria. Journal of travel medicine 20030101
Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attack. Transactions of the Royal Society of Tropical Medicine and Hygiene 20030101
In-vitro sensitivity testing of Plasmodium vivax: response to lumefantrine and chloroquine in northwestern Thailand. Wiener klinische Wochenschrift 20030101
Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects. British journal of clinical pharmacology 20021101
Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects. Journal of clinical pharmacology 20021001
[Efficacy of mefloquine, halofantrine, and coarteme in the treatment of tropical malaria]. Meditsinskaia parazitologiia i parazitarnye bolezni 20020101
[Riamet: a new antimalarial for curative treatment of malaria]. Medecine tropicale : revue du Corps de sante colonial 20020101
A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. The American journal of tropical medicine and hygiene 20010101
Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. British journal of clinical pharmacology 19981201

© 2019 Angene International Limited. All rights Reserved.